These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2174543)

  • 1. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.
    Capranico G; Kohn KW; Pommier Y
    Nucleic Acids Res; 1990 Nov; 18(22):6611-9. PubMed ID: 2174543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.
    Pommier Y; Capranico G; Orr A; Kohn KW
    Nucleic Acids Res; 1991 Nov; 19(21):5973-80. PubMed ID: 1658748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
    Pommier Y; Capranico G; Orr A; Kohn KW
    J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
    Fesen M; Pommier Y
    J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
    Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
    De Isabella P; Zunino F; Capranico G
    Nucleic Acids Res; 1995 Jan; 23(2):223-9. PubMed ID: 7862525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DA-125, a new antitumor agent, inhibits topoisomerase II as topoisomerase poison and DNA intercalator simultaneously.
    Seo J; Lee HS; Lee M; Kim M; Shin CG
    Arch Pharm Res; 2004 Jan; 27(1):77-82. PubMed ID: 14969343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
    Capranico G; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1990 Jan; 29(2):562-9. PubMed ID: 2154250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage.
    Bigioni M; Zunino F; Capranico G
    Nucleic Acids Res; 1994 Jun; 22(12):2274-81. PubMed ID: 8036155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
    Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
    Yang L; Rowe TC; Nelson EM; Liu LF
    Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleosome positioning as a critical determinant for the DNA cleavage sites of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin.
    Capranico G; Jaxel C; Roberge M; Kohn KW; Pommier Y
    Nucleic Acids Res; 1990 Aug; 18(15):4553-9. PubMed ID: 2167470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.
    Fossé P; René B; Le Bret M; Paoletti C; Saucier JM
    Nucleic Acids Res; 1991 Jun; 19(11):2861-8. PubMed ID: 1647520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
    Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
    Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
    Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
    Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA.
    Edwards KA; Halligan BD; Davis JL; Nivera NL; Liu LF
    Nucleic Acids Res; 1982 Apr; 10(8):2565-76. PubMed ID: 6281736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
    Jaxel C; Capranico G; Kerrigan D; Kohn KW; Pommier Y
    J Biol Chem; 1991 Oct; 266(30):20418-23. PubMed ID: 1657924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.